Averin Capital

Averin Capital is an investment firm focused on the convergence of technology and health, providing operational expertise and deep domain knowledge to scale visionary teams. The firm actively invests in transformative technologies that drive advancements in early disease detection, enhanced treatment delivery, personalized care, and medical breakthroughs, accelerating societal transformations within human health.

Founded in 2023 by Managing Partners David Berry, MD PhD, and Eric Berry, Averin Capital emerged from their extensive operational backgrounds. With experience founding, building, and scaling over 30 companies, their insight stems from a profound understanding of organizational growth. This battle-tested expertise and network now support the next generation of bold, visionary businesses.

Averin Capital partners with exceptional teams and visionary entrepreneurs dedicated to meaningful change in human health. The firm's mission centers on empowering these teams to unlock their fullest potential and confidently navigate challenges. Its long-term vision aims to deliver impactful innovations that significantly advance human health and societal well-being.